• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin J Am Soc Nephrol . The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Clin J Am Soc Nephrol


. 2020 Sep 22;CJN.04650420.
doi: 10.2215/CJN.04650420. Online ahead of print.
The Incidence, Risk Factors, and Prognosis of Acute Kidney Injury in Adult Patients with Coronavirus Disease 2019


Yichun Cheng[SUP] 1 [/SUP], Ran Luo[SUP] 1 [/SUP], Xu Wang[SUP] 2 [/SUP], Kun Wang[SUP] 1 [/SUP], Nanhui Zhang[SUP] 1 [/SUP], Meng Zhang[SUP] 1 [/SUP], Zhixiang Wang[SUP] 1 [/SUP], Lei Dong[SUP] 1 [/SUP], Junhua Li[SUP] 1 [/SUP], Rui Zeng[SUP] 1 [/SUP], Ying Yao[SUP] 1 [/SUP], Shuwang Ge[SUP] 3 [/SUP], Gang Xu[SUP] 3 [/SUP]



Affiliations

Abstract

Background and objectives: Since December 2019, coronavirus disease 2019 (COVID-19) outbreak occurred and has rapidly spread worldwide. However, little information is available about the AKI in COVID-19. We aimed to evaluate the incidence, risk factors, and prognosis of AKI in adult patients with COVID-19.
Design, setting, participants, & measurements: This was a retrospective cohort study of 1392 patients with COVID-19 admitted to a tertiary teaching hospital. Clinical characteristics and laboratory data were extracted from electronic hospitalization and laboratory databases. AKI was defined and staged according to the 2012 Kidney Disease: Improving Global Outcomes criteria. Risk factors for AKI and the association of AKI with in-hospital mortality were assessed.
Results: A total of 7% (99 of 1392) of patients developed AKI during hospitalization, 40% (40 of 99) of which occurred within 1 week of admission. Factors associated with a higher risk of AKI include severe disease (odds ratio [OR], 2.25; 95% confidence interval [CI], 1.37 to 3.67), higher baseline serum creatinine (OR, 2.19; 95% CI, 1.17 to 4.11), lymphopenia (OR, 1.99; 95% CI, 1.12 to 3.53), and elevated D-dimer level (OR, 2.68; 95% CI, 1.07 to 6.70). The in-hospital mortality in patients with AKI stage 1, stage 2, and stage 3 was 62%, 77%, and 80%, respectively. AKI was associated with in-hospital mortality even after adjustment for confounders (OR, 5.12; 95% CI, 2.70 to 9.72).
Conclusions: AKI is uncommon but carries high in-hospital mortality in patients with COVID-19.

Keywords: COVID-19; acute kidney injury; mortality; prognosis; risk factors.
 
Back
Top Bottom